» Articles » PMID: 18594983

Impairment by 5-fluorouracil of the Healing of Gastric Lesions in Rats: Effect of Lafutidine, a Histamine H2 Receptor Antagonist, Mediated by Capsaicin-sensitive Afferent Neurons

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2008 Jul 3
PMID 18594983
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the influence of 5-fluorouracil (5-FU), an anti-tumor agent, on the healing of gastric lesions generated by 0.6 M HCl in rats and the effect of lafutidine, a histamine H(2) receptor antagonist, on the impaired healing. Animals fasted for 18 h were given 1 ml of 0.6 M HCl p.o., fed normally from 1 h later, and killed 1-96 h thereafter. 5-FU was given i.v. twice, 1 h and 24 h after the HCl. The gastric lesions healed spontaneously within 96 h. Although it decreased acid secretion, 5-FU markedly delayed the healing. Lafutidine, but not cimetidine, given p.o. immediately after each dosing of 5-FU significantly reversed the delay in healing by 5-FU, and this effect was attenuated by the chemical ablation of capsaicin-sensitive afferent neurons. Capsaicin also significantly reversed the delay in healing. The mucosal application of 50 mM HCl did not affect gastric mucosal blood flow (GMBF) in the normal stomach, but significantly increased it in the stomach damaged by 0.6 M HCl. The increases in GMBF were attenuated by 5-FU; however, the co-administration of lafutidine significantly restored the response. In addition, 5-FU inhibited both cell proliferation and migration in rat gastric epithelial cells (RGM1) in vitro. These results suggest that 5-FU delayed the healing of gastric lesions generated by 0.6 M HCl, probably through the inhibition of cell migration and proliferation, as well as the impairment of GMBF, and lafutidine reversed the delay in healing, mainly through the amelioration of the GMBF response mediated by capsaicin-sensitive afferent neurons.

Citing Articles

Rocket "Eruca sativa": a salad herb with potential gastric anti-ulcer activity.

Alqasoumi S, Al-Sohaibani M, Al-Howiriny T, Al-Yahya M, Rafatullah S World J Gastroenterol. 2009; 15(16):1958-65.

PMID: 19399927 PMC: 2675085. DOI: 10.3748/wjg.15.1958.

References
1.
Takeuchi K, Ogawa Y, Kagawa S, Ukawa H . Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Aliment Pharmacol Ther. 2002; 16 Suppl 2:74-82. DOI: 10.1046/j.1365-2036.16.s2.21.x. View

2.
Hirata K, Horie T . A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine. Res Commun Mol Pathol Pharmacol. 2000; 104(3):243-51. View

3.
Fukushima K, Aoi Y, Kato S, Takeuchi K . Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J Gastroenterol. 2006; 12(19):3031-7. PMC: 4124377. DOI: 10.3748/wjg.v12.i19.3031. View

4.
Kotani T, Nakagiri A, Murashima Y, Takeuchi K . Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil. Inflammopharmacology. 2007; 15(5):203-8. DOI: 10.1007/s10787-007-1593-1. View

5.
Basaki Y, Chikahisa L, Aoyagi K, Miyadera K, Yonekura K, Hashimoto A . gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis. 2002; 4(3):163-73. DOI: 10.1023/a:1014059528046. View